CO4950555A1 - Composiciones farmaceuticas que contienen eleptriptan hemisulfato - Google Patents

Composiciones farmaceuticas que contienen eleptriptan hemisulfato

Info

Publication number
CO4950555A1
CO4950555A1 CO98037816A CO98037816A CO4950555A1 CO 4950555 A1 CO4950555 A1 CO 4950555A1 CO 98037816 A CO98037816 A CO 98037816A CO 98037816 A CO98037816 A CO 98037816A CO 4950555 A1 CO4950555 A1 CO 4950555A1
Authority
CO
Colombia
Prior art keywords
hemisulfate
eleptriptan
pharmaceutical compositions
compositions containing
caffeine
Prior art date
Application number
CO98037816A
Other languages
English (en)
Inventor
Valerie Denise Harding
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO4950555A1 publication Critical patent/CO4950555A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición farmacéutica acuosa que comprende de 5 a 200mg/ml de eletriptán hemisulfato y del 0,5 a 2,0% en peso/volumen de cafeína.1Una composición según la reivindicación 1, que comprende 120 mg/ml de eletriptán hemisulfato,1.5% en peso/volumen de cafeína,0.3% en peso/volumen de ácido cítrico y 5% en peso/volumen de etanolestando la composición tamponada a pH de 7.5 a 8.5, con preferencia aproximadamente pH 8.0.
CO98037816A 1997-07-03 1998-07-03 Composiciones farmaceuticas que contienen eleptriptan hemisulfato CO4950555A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CO4950555A1 true CO4950555A1 (es) 2000-09-01

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98037816A CO4950555A1 (es) 1997-07-03 1998-07-03 Composiciones farmaceuticas que contienen eleptriptan hemisulfato

Country Status (13)

Country Link
KR (1) KR100384346B1 (es)
AP (1) AP1100A (es)
AR (1) AR013165A1 (es)
CO (1) CO4950555A1 (es)
GB (2) GB9714081D0 (es)
GT (1) GT199800105A (es)
HN (1) HN1998000101A (es)
MY (1) MY119643A (es)
PA (1) PA8454501A1 (es)
PE (1) PE84499A1 (es)
TN (1) TNSN98126A1 (es)
UA (1) UA49955C2 (es)
ZA (1) ZA985812B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
UA49955C2 (uk) 2002-10-15
TNSN98126A1 (fr) 2005-03-15
MY119643A (en) 2005-06-30
KR20010014366A (ko) 2001-02-26
GT199800105A (es) 2000-01-04
AR013165A1 (es) 2000-12-13
AP9801290A0 (en) 1998-09-30
PA8454501A1 (es) 2000-05-24
ZA985812B (en) 2000-01-10
AP1100A (en) 2002-09-02
GB9714081D0 (en) 1997-09-10
KR100384346B1 (ko) 2003-05-16
HN1998000101A (es) 1999-01-08
PE84499A1 (es) 1999-09-11
GB9718270D0 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
ES2163291T3 (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato y cafeina.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
BG102894A (en) Aryl-heterocyclic salts-including complexes
AR030245A1 (es) Composiciones de gel que contienen metronidazol
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
NO304261B1 (no) Preparat omfattende en lipofil forbindelse
EE05072B1 (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
ATE541562T1 (de) Ibuprofen-suspension
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
ES2082012T3 (es) Inhibidores de la enzima beta-liasa de aminoacido como desodorantes.
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
MY135548A (en) Aqueous preparation containing oligopeptides and etherified cyclodextrin
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
WO2001030391A3 (en) Pharmaceutical composition containing midazolam
CO4950555A1 (es) Composiciones farmaceuticas que contienen eleptriptan hemisulfato
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
ECSP982578A (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
ES2156763A1 (es) Formulacion estables de solucion de apomorfina.
AR023056A1 (es) Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
GT199800204A (es) Composicion farmaceutica bebible.
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
MX9601756A (es) Composicion liquida estable que contiene urato-oxidasa, y composicion liofilizada para su preparacion.